Niramoy Pharmacy Private Limited
Founded in 2023 and headquartered in West Bengal, India.
2023 | Kolkata, West Bengal (India) | Active
Niramoy Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 1 Year 7 Months
- Open Charges ₹ 8.51 M
About Niramoy Pharmacy
Niramoy Pharmacy Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2023 (One year and seven months 21 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹8.51 M.
Alina Mazumdar, Maitreyi Datta, Niladri Datta, and One other member serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U47721WB2023PTC263403
- Company No.
263403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Pharma
Who are the key members and board of directors at Niramoy Pharmacy?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alina Mazumdar  | Director | 10-Jul-2023 | Current |
| Maitreyi Datta | Director | 10-Jul-2023 | Current |
| Niladri Datta | Director | 10-Jul-2023 | Current |
| Nirjhar Datta | Director | 10-Jul-2023 | Current |
Financial Performance of Niramoy Pharmacy.
Enhance accessibility to Niramoy Pharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Niramoy Pharmacy?
Unlock access to Niramoy Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Alinex Leisure Hotels Private Limited
Alina Mazumdar and Maitreyi Datta are mutual person
- Saltee Hospitality Services Private Limited
Alina Mazumdar is a mutual person
Charges (Loans)
Open Charges
₹8.51 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2024 | Others | ₹8.51 M | Open |
How Many Employees Work at Niramoy Pharmacy?
Unlock and access historical data on people associated with Niramoy Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Niramoy Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niramoy Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.